North America Medical Second Opinion Market Report (2021–2031) by Scope, Segmentation, Dynamics, and Competitive Analysis.
The North America Medical Second Opinion Market size was valued at US$ 2,485.58 Mn in 2023 and is projected to reach US$ 7,306.96 Mn by 2031, growing at a CAGR of 14.4% during 2023 - 2031.
Report Coverage
- Condition: Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematological Blood Disorders, COPD, Organ Transplant, Others
- Service Provider: Hospitals, Health Insurance Companies, Online Services
US$ 2,485.58 Mn
Market size in 2023
US$ 7,306.96 Mn
Market Size by 2031
14.4%
CAGR, 2023 - 2031
2024-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Medical Second Opinion Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Medical Second Opinion Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Medical Second Opinion Market Regional Analysis
6.2 North America Medical Second Opinion Market Revenue 2021-2031 (US$ Million)
6.3 North America Medical Second Opinion Market Forecast Analysis
7. North America Medical Second Opinion Market Analysis – by Condition
7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.6 Hematological Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Blood Disorders: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.8 Organ Transplant
- 7.8.1 Overview
- 7.8.2 Organ Transplant: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. North America Medical Second Opinion Market Analysis – by Service Provider
8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services: North America Medical Second Opinion Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. North America Medical Second Opinion Market – North America Analysis
9.1 Overview
9.2 North America- 9.2.1 North America Medical Second Opinion Market Breakdown, by Key Country, 2024 and 2031 (%)
- 9.2.1.1 North America Medical Second Opinion Market – Revenue and Forecast Analysis – by Country
- 9.2.1.1 US: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.1.1 US: North America Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.1.2 US: North America Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.2 Canada: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.2.1 Canada: North America Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.2.2 Canada: North America Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.1.3 Mexico: North America Medical Second Opinion Market – Revenue and Forecast to 2031 (US$ Million)
- 9.2.1.3.1 Mexico: North America Medical Second Opinion Market Breakdown, by Condition
- 9.2.1.3.2 Mexico: North America Medical Second Opinion Market Breakdown, by Service Provider
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Second Opinion International
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Elite Medical Services
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 The Cigna Group
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Helsana
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 WorldCare
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Vidal Health Insurance TPA Pvt Ltd
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 2nd.MD
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Axa SA
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Teladoc Health Inc
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Included Health, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Royal Doctors
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Access the Full N Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
